(19)
(11) EP 1 861 079 A1

(12)

(43) Date of publication:
05.12.2007 Bulletin 2007/49

(21) Application number: 06710166.7

(22) Date of filing: 08.03.2006
(51) International Patent Classification (IPC): 
A61K 31/10(2006.01)
C07C 317/14(2006.01)
A61P 25/00(2006.01)
A61K 31/18(2006.01)
A61K 31/415(2006.01)
A61K 31/4184(2006.01)
A61K 31/426(2006.01)
C07D 213/82(2006.01)
A61K 31/44(2006.01)
C07D 213/71(2006.01)
A61K 31/166(2006.01)
A61K 31/277(2006.01)
A61K 31/4164(2006.01)
A61K 31/4196(2006.01)
C07D 213/80(2006.01)
(86) International application number:
PCT/GB2006/050048
(87) International publication number:
WO 2006/097766 (21.09.2006 Gazette 2006/38)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 17.03.2005 GB 0505437

(71) Applicant: MERCK SHARP & DOHME LTD.
Hoddesdon, Hertfordshire EN11 9BU (GB)

(72) Inventors:
  • CHAMBERS, Mark Stuart
    Harlow, Essex CM20 2QR (GB)
  • GILLIGAN, Myra
    Harlow, Essex CM20 2QR (GB)
  • HUMPHRIES, Alexander Charles
    Harlow, Essex CM20 2QR (GB)
  • MERCHANT, Kevin John
    Harlow, Essex CM20 2QR (GB)

(74) Representative: Buchan, Gavin MacNicol et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU
Hertfordshire, EN11 9BU (GB)

   


(54) ARYLSULFONYL BENZYL ETHERS AS 5-HT2A ANTAGONISTS